Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190217042735N1Phase 3Completed
Phase 3, randomised, double-blind trial in Nausea and Vomiting comparing Olanzapine, Aprepitant + Kytril and Granisetron (3 arms). Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190217042735N1.